mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.3 |
mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
-0.17 |
0.3 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Bicalutamide |
FIMM |
pan-cancer |
AAC |
-0.16 |
0.3 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |